Login / Signup

Real-world safety and effectiveness of secukinumab in adult patients with moderate to severe plaque psoriasis: results from postmarketing surveillance in Korea.

Byung Soo KimDong Hyun KimBong Seok ShinEun-So LeeSeong Jin JoChul Hwan BangYeojun YunYong Beom Choe
Published in: Therapeutic advances in chronic disease (2024)
Secukinumab showed sustained effectiveness and favorable safety profile in adult patients with moderate to severe psoriasis in Korea.
Keyphrases
  • ankylosing spondylitis
  • randomized controlled trial
  • systematic review
  • high intensity
  • early onset
  • public health
  • coronary artery disease
  • drug induced
  • disease activity